SG Americas Securities, LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$46
-8.0%
11,316
-40.0%
0.00%
Q4 2023$50
+6.4%
18,857
-5.3%
0.00%
-100.0%
Q3 2023$47
-46.0%
19,907
+32.4%
0.00%0.0%
Q1 2023$87
-99.9%
15,040
+51.4%
0.00%
-50.0%
Q3 2022$166,000
+0.6%
9,936
-15.9%
0.00%0.0%
Q2 2022$165,000
+36.4%
11,812
+109.5%
0.00%
+100.0%
Q4 2021$121,0005,6390.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$41,116,79917.73%
Logos Global Management LP 2,797,501$17,624,2562.40%
Cormorant Asset Management, LP 5,150,000$32,445,0001.82%
RA Capital Management 2,971,231$18,718,7550.35%
Avoro Capital Advisors LLC 3,500,000$22,050,0000.30%
RTW INVESTMENTS, LP 1,563,031$9,847,0950.19%
GSA CAPITAL PARTNERS LLP 238,200$1,5010.15%
Virtus ETF Advisers LLC 20,137$126,8630.08%
Rock Springs Capital Management LP 460,391$2,900,4630.07%
Corton Capital Inc. 17,323$109,1350.05%
View complete list of DESIGN THERAPEUTICS INC shareholders